2022
DOI: 10.1080/10408398.2022.2055526
|View full text |Cite
|
Sign up to set email alerts
|

Hypoglycemic bioactivity of anthocyanins: A review on proposed targets and potential signaling pathways

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
14
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(14 citation statements)
references
References 128 publications
0
14
0
Order By: Relevance
“…In addition, anthocyanins play a protective role in cardiovascular diseases through the increment of PPAR and the downregulation of CD36 expression to prevent platelet aggregation and LDL oxidation; moreover, anthocyanins increase polyunsaturated fatty acid levels over saturated fatty acid levels [ 12 , 16 , 17 , 18 ]. Furthermore, these pigments have hypoglycemic and anti-obesity properties by increasing GLUT4 expression through AMPK activation leading to better glucose catchment by muscles and fat tissue [ 19 , 20 ]. Furthermore, anthocyanins decrease PEPCK expression and upregulate PPAR, CPT1A, and ACO, providing a reduction in lipid liver levels [ 21 , 22 ].…”
Section: Introductionmentioning
confidence: 99%
“…In addition, anthocyanins play a protective role in cardiovascular diseases through the increment of PPAR and the downregulation of CD36 expression to prevent platelet aggregation and LDL oxidation; moreover, anthocyanins increase polyunsaturated fatty acid levels over saturated fatty acid levels [ 12 , 16 , 17 , 18 ]. Furthermore, these pigments have hypoglycemic and anti-obesity properties by increasing GLUT4 expression through AMPK activation leading to better glucose catchment by muscles and fat tissue [ 19 , 20 ]. Furthermore, anthocyanins decrease PEPCK expression and upregulate PPAR, CPT1A, and ACO, providing a reduction in lipid liver levels [ 21 , 22 ].…”
Section: Introductionmentioning
confidence: 99%
“…Diabetes mellitus (DM) is a common endocrine metabolic disorder accompanied by glucose, fat, and protein metabolism disorders caused by insulin secretion and/or functional deficiencies . The global prevalence of DM is growing rapidly, and the number of patients with diabetes is estimated to be 463 million in 2019, which is expected to increase to 578 million by 2030 and 700 million by 2045 .…”
Section: Introductionmentioning
confidence: 99%
“…Diabetes mellitus (DM) is a common endocrine metabolic disorder accompanied by glucose, fat, and protein metabolism disorders caused by insulin secretion and/or functional deficiencies. 1 The global prevalence of DM is growing rapidly, and the number of patients with diabetes is estimated to be 463 million in 2019, which is expected to increase to 578 million by 2030 and 700 million by 2045. 2 Without effective treatment, diabetes mellitus (DM) will result in severe complications in various body tissues or organs, such as liver dysfunction, renal failure, blindness, and nervous system damage.…”
Section: Introductionmentioning
confidence: 99%
“…Diabetes consists of two major subtypes, type 1 and type 2, where type 2 diabetes (T2D) makes up about 90% of the cases ( 1 ). The outstanding character of T2D is the systemic metabolic disturbances including elevated blood glucose and lipid content level ( 2 , 3 ). Glucose toxicity ( 4 , 5 ) and lipid toxicity ( 6 , 7 ) are the two major metabolic insults to those energy-demanding organs such as the heart.…”
Section: Introductionmentioning
confidence: 99%